{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:57:53Z","timestamp":1792828673397,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11102-012-0457-x","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T12:03:43Z","timestamp":1357733023000},"page":"459-464","source":"Crossref","is-referenced-by-count":37,"title":["Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications"],"prefix":"10.1007","volume":"16","author":[{"given":"Thomas J.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel L.","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"key":"457_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159:89\u201395. doi: 10.1530\/EJE-08-0267","journal-title":"Eur J Endocrinol"},{"key":"457_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93:61\u201367. doi: 10.1210\/jc.2007-1191","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR3","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141\u20133148. doi: 10.1210\/jc.2009-2670","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000095533","volume":"83","author":"DK Ludecke","year":"2006","unstructured":"Ludecke DK, Abe T (2006) Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 83:230\u2013239. doi: 10.1159\/000095533","journal-title":"Neuroendocrinology"},{"key":"457_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019. Eur J Endocrinol 152:379\u2013387. doi: 10.1530\/eje.1.01863","journal-title":"Eur J Endocrinol"},{"key":"457_CR6","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1210\/jc.2002-021822","volume":"88","author":"P De","year":"2003","unstructured":"De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF (2003) Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 88:3567\u20133572","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","volume":"58","author":"C Beauregard","year":"2003","unstructured":"Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86\u201391","journal-title":"Clin Endocrinol (Oxf)"},{"key":"457_CR8","first-page":"1239","volume":"48","author":"I Shimon","year":"2001","unstructured":"Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48:1239\u20131245","journal-title":"Neurosurgery"},{"key":"457_CR9","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2010.7.FOCUS10173","volume":"29","author":"CP Hofstetter","year":"2010","unstructured":"Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH (2010) Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E6. doi: 10.3171\/2010.7.FOCUS10173","journal-title":"Neurosurg Focus"},{"key":"457_CR10","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2010.7.FOCUS10167","volume":"29","author":"JA Gondim","year":"2010","unstructured":"Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 29:E7. doi: 10.3171\/2010.7.FOCUS10167","journal-title":"Neurosurg Focus"},{"key":"457_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2176\/nmc.49.1","volume":"49","author":"S Yano","year":"2009","unstructured":"Yano S, Kawano T, Kudo M, Makino K, Nakamura H, Kai Y, Morioka M, Kuratsu J (2009) Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo) 49:1\u20137","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"457_CR12","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96:2732\u20132740. doi: 10.1210\/jc.2011-0554","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR13","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jc.86.4.1645","volume":"86","author":"GA Kaltsas","year":"2001","unstructured":"Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:1645\u20131652","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/2007.12.17635","volume":"111","author":"A Tabaee","year":"2009","unstructured":"Tabaee A, Anand VK, Barron Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545\u2013554. doi: 10.3171\/2007.12.17635","journal-title":"J Neurosurg"},{"key":"457_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013618","journal-title":"Neurosurgery"},{"key":"457_CR16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3171\/2012.4.JNS11739","volume":"117","author":"NF Marko","year":"2012","unstructured":"Marko NF, Lasota E, Hamrahian AH, Weil RJ (2012) Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly. J Neurosurg 117:522\u2013538. doi: 10.3171\/2012.4.JNS11739","journal-title":"J Neurosurg"},{"key":"457_CR17","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jc.82.10.3187","volume":"82","author":"AL Barkan","year":"1997","unstructured":"Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187\u20133191","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR18","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.85.5.2068","volume":"85","author":"JS Powell","year":"2000","unstructured":"Powell JS, Wardlaw SL, Post KD, Freda PU (2000) Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 85:2068\u20132071","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1210\/jc.85.7.2476","volume":"85","author":"NR Biermasz","year":"2000","unstructured":"Biermasz NR, van Dulken H, Roelfsema F (2000) Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 85:2476\u20132482","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR20","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jc.85.10.3779","volume":"85","author":"G Barrande","year":"2000","unstructured":"Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:3779\u20133785","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1450717","volume":"145","author":"R Cozzi","year":"2001","unstructured":"Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R (2001) Failure of radiotherapy in acromegaly. Eur J Endocrinol 145:717\u2013726","journal-title":"Eur J Endocrinol"},{"key":"457_CR22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jc.2005-1616","volume":"91","author":"PJ Jenkins","year":"2006","unstructured":"Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91:1239\u20131245. doi: 10.1210\/jc.2005-1616","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-007-0002-5","volume":"10","author":"RS Jallad","year":"2007","unstructured":"Jallad RS, Musolino NR, Salgado LR, Bronstein MD (2007) Treatment of acromegaly: is there still a place for radiotherapy? Pituitary 10:53\u201359. doi: 10.1007\/s11102-007-0002-5","journal-title":"Pituitary"},{"issue":"Suppl 3","key":"457_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3171\/jns.2000.93.supplement_3.0019","volume":"93","author":"M Izawa","year":"2000","unstructured":"Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K (2000) Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93(Suppl 3):19\u201322. doi: 10.3171\/jns.2000.93.supplement3.0019","journal-title":"J Neurosurg"},{"issue":"Suppl 3","key":"457_CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3171\/jns.2000.93.supplement_3.0006","volume":"93","author":"N Zhang","year":"2000","unstructured":"Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW (2000) Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 93(Suppl 3):6\u20139. doi: 10.3171\/jns.2000.93.supplement3.0006","journal-title":"J Neurosurg"},{"key":"457_CR26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2002-021663","volume":"88","author":"R Attanasio","year":"2003","unstructured":"Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88:3105\u20133112","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR27","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2005-0311","volume":"90","author":"F Castinetti","year":"2005","unstructured":"Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Regis J, Dufour H, Brue T (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90:4483\u20134488. doi: 10.1210\/jc.2005-0311","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2006.02513.x","volume":"64","author":"J Jezkova","year":"2006","unstructured":"Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, Lisak R, Vymazal J, Pecen L (2006) Gamma knife radiosurgery for acromegaly\u2013long-term experience. Clin Endocrinol (Oxf) 64:588\u2013595. doi: 10.1111\/j.1365-2265.2006.02513.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"457_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3171\/jns.2007.106.5.833","volume":"106","author":"BE Pollock","year":"2007","unstructured":"Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106:833\u2013838. doi: 10.3171\/jns.2007.106.5.833","journal-title":"J Neurosurg"},{"key":"457_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-07-0189","volume":"157","author":"EO Vik-Mo","year":"2007","unstructured":"Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rodahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2007) Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol 157:255\u2013263. doi: 10.1530\/EJE-07-0189","journal-title":"Eur J Endocrinol"},{"key":"457_CR31","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1210\/jc.2008-0135","volume":"93","author":"M Losa","year":"2008","unstructured":"Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, Mortini P (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93:2546\u20132552. doi: 10.1210\/jc.2008-0135","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","volume":"114","author":"JP Sheehan","year":"2011","unstructured":"Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303\u2013309. doi: 10.3171\/2010.5.JNS091635","journal-title":"J Neurosurg"},{"key":"457_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/eje.0.1430577","volume":"143","author":"JA Verhelst","year":"2000","unstructured":"Verhelst JA, Pedroncelli AM, Abs R, Montini M, Vandeweghe MV, Albani G, Maiter D, Pagani MD, Legros JJ, Gianola D, Bex M, Poppe K, Mockel J, Pagani G (2000) Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. Eur J Endocrinol 143:577\u2013584","journal-title":"Eur J Endocrinol"},{"key":"457_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jc.87.1.99","volume":"87","author":"P Caron","year":"2002","unstructured":"Caron P, Beckers A, Cullen DR, Goth MI, Gutt B, Laurberg P, Pico AM, Valimaki M, Zgliczynski W (2002) Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly. J Clin Endocrinol Metab 87:99\u2013104","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR35","doi-asserted-by":"crossref","unstructured":"Caron P, Bex M, Cullen DR, Feldt-Rasmussen U, Pico Alfonso AM, Pynka S, Racz K, Schopohl J, Tabarin A, Valimaki MJ (2004) One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel. Clin Endocrinol (Oxf) 60:734\u2013740. doi: 10.1111\/j.1365-2265.2004.02045.x","DOI":"10.1111\/j.1365-2265.2004.02045.x"},{"key":"457_CR36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.2006.02450.x","volume":"64","author":"P Caron","year":"2006","unstructured":"Caron P, Cogne M, Raingeard I, Bex-Bachellerie V, Kuhn JM (2006) Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly. Clin Endocrinol (Oxf) 64:209\u2013214. doi: 10.1111\/j.1365-2265.2006.02450.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"457_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2008.03208.x","volume":"69","author":"P Chanson","year":"2008","unstructured":"Chanson P, Borson-Chazot F, Kuhn JM, Blumberg J, Maisonobe P, Delemer B (2008) Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48\u00a0weeks in patients with acromegaly. Clin Endocrinol (Oxf) 69:299\u2013305. doi: 10.1111\/j.1365-2265.2008.03208.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"457_CR38","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1210\/jc.83.9.3034","volume":"83","author":"CB Newman","year":"1998","unstructured":"Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL (1998) Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 83:3034\u20133040","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR39","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.86.6.2779","volume":"86","author":"A Colao","year":"2001","unstructured":"Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G (2001) Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779\u20132786","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR40","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1210\/jc.2001-012012","volume":"87","author":"JS Bevan","year":"2002","unstructured":"Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM (2002) Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 87:4554\u20134563","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000081418","volume":"62","author":"PJ Jenkins","year":"2004","unstructured":"Jenkins PJ, Emery M, Howling SJ, Evanson J, Besser GM, Monson JP (2004) Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR. Horm Res 62:227\u2013232. doi: 10.1159\/000081418","journal-title":"Horm Res"},{"key":"457_CR42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2265.2005.02317.x","volume":"63","author":"RS Jallad","year":"2005","unstructured":"Jallad RS, Musolino NR, Salgado LR, Bronstein MD (2005) Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Clin Endocrinol (Oxf) 63:168\u2013175. doi: 10.1111\/j.1365-2265.2005.02317.x","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-012-0457-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-012-0457-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-012-0457-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T23:36:32Z","timestamp":1562542592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-012-0457-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1007\/s11102-012-0457-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}